Resveratrol (3,5,4’-trihydroxy-trans-stilbene, RV) is a kind of phytoalexin found in many kinds of plants and food. As a natural antioxidant, RV shows significant biological activity, including anti-tumor activity, antitubulin activity, cardiovascular disease resistance activity, etc. Many experiments confirm that resveratrol displays a wide range of beneficial effects on human diseases including heart disease and cancer, especially in the treatment of central nervous system disease, such as Huntington’s disease (HD), Alzheimer’s disease (AD) and Parkinson’s disease (PD). This paper summarizes the positive effects of RV on several central nervous system diseases.
KeywordsResveratrolCentral Nervous System DiseasesDisease TreatmentAlzheimer’s Disease
Sparvoli, F., Martin, C., Scienza, A., Gavazzi, G. and Tonelli, C. (1994) Cloning and Molecular Analysis of Structural Genes Involved in Flavonoid and Stilbene Biosynthesis in Grape (Vitis vinifera L.). Plant Molecular Biology, 24, 743-755. http://dx.doi.org/10.1007/BF00029856
Wang, Q., Xu, J., Rottinghaus, G., Simonyi, A., Lubahn, D., Sun, G.Y. and Sun, A.Y. (2002) Resveratrol Protects against Global Cerebral Ischemic Injury in Gerbils. Brain Research, 958, 439-447. http://dx.doi.org/10.1016/S0006-8993(02)03543-6
Rocha-Gonzalez, H., Ambriz-Tututi, M. and Granados-Soto, V. (2008) Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics, 14, 234-247. http://dx.doi.org/10.1111/j.1755-5949.2008.00045.x
Selkoe, D.J. (2002) Alzheimer’s disease Is a Synaptic Failure. Science, 298, 789-791. http://dx.doi.org/10.1126/science.1074069
Tanzi, R.E. (2005) The Synaptic Aβ Hypothesis of Alzheimer Disease. Nature Neuroscience, 8, 977-979. http://dx.doi.org/10.1038/nn0805-977
Saraqoni, L., Hernandez, P. and Maccioni, R.B. (2000) Differential Association of Tau with Subsets of Microtubules Containing Posttranslationally-Modified Tubulin Variants in Neuroblastoma Cells. Neurochemical Research, 25, 59-70. http://dx.doi.org/10.1023/A:1007587315630
Smith, M.J., Crowther, R.A. and Goedert, M. (2000) The Natural Osmolytetrimethylamine N-Oxide (TMAO) Restores the Ability of Mutant Tau to Promote Microtubule Assembly. FEBS Letters, 484, 265-270. http://dx.doi.org/10.1016/S0014-5793(00)02169-4
Takashima, A., Honda, T., Yasutake, K., et al. (1998) Activation of Tau Protein Kinasel/Glycogen Synthase Kinase-3Beta by Amyloid Beta Peptide (25-35) Enhances Phosphorylation of Tau in Hippocampal Neurons. Neuroscience Research, 31, 317-323. http://dx.doi.org/10.1016/S0168-0102(98)00061-3
Cuello, A.C. (2005) Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies. Brain Pathology, 15, 66-71. http://dx.doi.org/10.1111/j.1750-3639.2005.tb00101.x
Ethell, D.W. and Buhler, L.A. (2003) Fas Ligand-Mediated Apoptosis in Degenerative Disorders of the Brain. Journal of Clinical Immunology, 23, 439-446. http://dx.doi.org/10.1023/B:JOCI.0000010420.96419.a8
Dudek, H., Datta, S.R., Franke, T.F., Birnbaum, M.J., Yao, R., Cooper, G.M., Segal, R.A., Kaplan, D.R. and Greenberg, M.E. (1997) Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt. Science, 275, 661-665. http://dx.doi.org/10.1126/science.275.5300.661
Gertz, M., Nquyen, G.T., Fischer, F., et al. (2012) A Molecular Mechanism for Direct Sirtuin Activation by Resveratrol. PLoS ONE, 7, e49761. http://dx.doi.org/10.1371/journal.pone.0049761
Feng, Y., Wang, X.P., Yang, S.G., et al. (2009) Resveratrol Inhibits Beta-Amyloid Oligomeric Cytotoxicity But Does Not Prevent Oligomer Formation. Neuro Toxicology, 30, 986-995. http://dx.doi.org/10.1016/j.neuro.2009.08.013
Cohen, T.J., Guo, J.L., Hurtado, D.E., Kwong, L.K., Mills, I.P., Trojanowski, J.Q. and Lee, V.M.Y. (2011) The Acetylation of Tau Inhibits Its Function and Promotes Pathological Tau Aggregation. Nature Communications, 2, Article No. 252. http://dx.doi.org/10.1038/ncomms1255
Vonsattel, J.P. and Figlia, M.D. (1998) Huntington Disease. Journal of Neuropathology & Experimental Neurology, 57, 369-384. http://dx.doi.org/10.1097/00005072-199805000-00001
MacDonald, M.E., Ambrose, C.M., Duyao, M.P., et al. (1993) A Novel Gene Containing a Trinucleotide Repeat That Is Expanded and Unstable on Huntington’s Disease Chromosomes. Cell, 72, 971-983. http://dx.doi.org/10.1016/0092-8674(93)90585-E
Lajoie, P. and Snapp, E.L. (2010) Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells. PLoS ONE, 5, e15245. http://dx.doi.org/10.1371/journal.pone.0015245
Kumar, P., Padi, S.S., Naidu, P.S., et al. (2007) Cyclooxygenase Inhibition Attenuates 3-Nitropropionic Acid-Induced Neurotoxicity in Rats: Possible Antioxidant Mechanisms. Fundamental & Clinical Pharmacology, 21, 297-306. http://dx.doi.org/10.1111/j.1472-8206.2007.00485.x
Feng, X., Liang, N., Zhu, D., et al. (2013) Resveratrol Inhibits β-Amyloid-Induced Neuronal Apoptosis through Regulation of SIRT1-ROCK1 Signaling Pathway. PLoS ONE, 8, e59888. http://dx.doi.org/10.1371/journal.pone.0059888
Bae, B.I., Xu, H., Igarashi, S., et al. (2005) P53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease. Neuron, 47, 29-41. http://dx.doi.org/10.1016/j.neuron.2005.06.005
Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L. and Gu, W. (2001) Negative Control of P53 by Sir2Alpha Promotes Cell Survival under Stress. Cell, 107, 137-148. http://dx.doi.org/10.1016/S0092-8674(01)00524-4
Zhou, S., Kachhap, S. and Singh, K.K. (2003) Mitochondrial Impairment in P53-Deficient Human Cancer Cells. Mutagenesis, 18, 287-292. http://dx.doi.org/10.1093/mutage/18.3.287
Canto, C. and Auxerx, J. (2012) Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD(+)? Pharmacological Reviews, 64, 166-187. http://dx.doi.org/10.1124/pr.110.003905
Choi, K.M., Lee, H.L., Kwon, Y.Y., Kang, M.S., Lee, S.K. and Lee, C.K. (2013) Enhancement of Mitochondrial Function Correlates with the Extension of Lifespan by Caloric Restriction and Caloric restriction Mimetics in Yeast. Biochemical and Biophysical Research Communications, 441, 236-242. http://dx.doi.org/10.1016/j.bbrc.2013.10.049
Barbato, D.L., Baldelli, S., Pagliei, B., et al. (2012) Caloric Restriction and the Nutrient-Sensing PGC-1α in Mitochondrial Homeostasis: New Perspectives in Neurodegeneration. International Journal of Cell Biology, 2012, Article ID: 759583.
de Rijk, M.C., Tzourio, C., Breteler, M.M., Dartigues, J.F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J.M., Alpérovitch, A. and Rocca, W.A. (1997) Prevalence of Parkinsonism and Parkinson’s Disease in Europe: The EURO- PARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson’s Disease. Journal of Neurology, Neurosurgery, and Psychiatry, 62, 10-15. http://dx.doi.org/10.1136/jnnp.62.1.10
Blesa, J., Phani, S., Jackson-Lewis, V., et al. (2012) Classic and New Animal Models of Parkinson’s Disease. Journal of Biomedicine and Biotechnology, 2012, Article ID: 845618.
Ferretta, A., Gaballo, A., Tanzarella, P., et al. (2014) Effect of Resveratrol on Mitochondrial Function: Implications in Parkin-Associated Familiar Parkinson’s Disease. Biochimica et Biophysica Acta (BBA): Molecular Basis of Disease, 1842, 902-915. http://dx.doi.org/10.1016/j.bbadis.2014.02.010
Vaarmann, A., Gandhi, S. and Abramov, A.Y. (2010) Dopamine Induces Ca2+ Signaling in Astrocytes through Reactive Oxygen Species Generated by Monoamine Oxidase. Journal of Biological Chemistry, 285, 25018-25023. http://dx.doi.org/10.1074/jbc.M110.111450
Surmeier, D.J., Guzman, J.N., Sanchez-Padilla, J. and Goldberg, J.A. (2011) The Origins of Oxidant Stress in Parkinson’s Disease and Therapeutic Strategies. Antioxidants & Redox Signaling, 14, 1289-1301. http://dx.doi.org/10.1089/ars.2010.3521
Duncan, R.S., Goad, D.L, Grillo, M.A., Kaja, S., Payme, A.J. and Koulen, P. (2010) Control of Intracellular Calcium Signaling as a Neuroprotective Strategy. Molecules, 15, 1168-1195. http://dx.doi.org/10.3390/molecules15031168
Donmez, G., Arun, A., Chung, C.Y., McLean, P.J., Lindquist, S. and Guarente, L. (2012) SIRT1 Protects against Alpha-Synuclein Aggregation by Activating Molecular Chaperones. The Journal of Neuroscience, 32, 124-132. http://dx.doi.org/10.1523/JNEUROSCI.3442-11.2012
Li, D.W., Liu, Z.Q., Chen, W., Yao, M. and Li, G.R. (2014) Association of Glycogen Synthase Kinase-3β with Parkinson’s Disease (Review). Molecular Medicine Reports, 9, 2043-2050. http://dx.doi.org/10.3892/mmr.2014.2080
Simao, F., Matte, A., Pagnussat, A.S., Netto, C.A. and Salbego, C.G. (2012) Resveratrol Prevents CA1 Neurons against Ischemic Injury by Parallel Modulation of Both GSK-3β and CREB through PI3-K/Akt Pathways. European Journal of Neuroscience, 36, 2899-2905. http://dx.doi.org/10.1111/j.1460-9568.2012.08229.x
Vang, O., Ahmad, N., Baile, C.A., Baur, J.A., Brown, K., Csiszar, A., et al. (2011) What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol. PLoS ONE, 6, e19881. http://dx.doi.org/10.1371/journal.pone.0019881